Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

Researchers from the University of Skövde, the University of Gothenburg, and the Sahlgrenska Academy have significantly ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

A new study focusing on the common CA-125 blood test found that some populations didn’t show elevated markers at diagnosis ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Researchers have made significant advances in early detection of gynaecological cancer. They have identified biomarkers that ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...